Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Galmed Pharmaceuticals Ltd. sell Bank of America Co.

Galmed Pharmaceuticals Ltd.
Start price
€6.40
06.11.24 / 50%
Target price
€74.68
06.11.25
Performance (%)
-
End price
-
07.11.25
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Galmed Pharmaceuticals Ltd. - - -
iShares Core DAX® 0,79 % 1,97 % 13,39 %
iShares Nasdaq 100 4,23 % 4,34 % 39,72 %
iShares Nikkei 225® 3,29 % 6,99 % 49,89 %
iShares S&P 500 2,50 % 2,76 % 30,23 %

Comments by Bank_of_America_Co_ for this prediction

In the thread Galmed Pharmaceuticals Ltd. diskutieren
Prediction Sell
Perf. (%) -
Target price 74.680
Change
Ends at 06.11.25

Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Bank of America Co. from $55.00 to $80.00. They now have an "underperform" rating on the stock.
Ratings data for GMED provided by MarketBeat

Bank of America Co. 
0
Report Share
06.11.24
In the thread Trading Galmed Pharmaceuticals Ltd.
Prediction Sell
Perf. (%) -
Target price 74.680
Change
Ends at 06.11.25

Die von Bank_of_America_Co_ gewählte maximale Laufzeit wurde überschritten

Bank of America Co. 
0
Report Share
07.11.25

Current prediction by Bank_of_America_Co_ for Galmed Pharmaceuticals Ltd.

buy
Galmed Pharmaceuticals Ltd.

Start price
Target price
Perf. (%)
€6.40
07.11.25
€78.87
07.11.26
-
19.09.24

Bank of America Co. 
07.11.25 50%